HP-1 develops and markets a focus-enhancing supplement offered as 60-capsule monthly supplies priced at £34.99 on HP-1.com. The product was formulated by co-founder Jeremy Lynch in partnership with Daniel Herman of Bio-Synergy, a NASM-qualified nutritionist with nearly three decades of sports-nutrition experience. The company positions its capsules as an everyday aid for sustained concentration and productivity. With its newly raised capital, HP-1 plans to scale operations and accelerate further product development. The founders aim to broaden distribution beyond direct-to-consumer sales on their website. Although detailed revenue or user metrics were not disclosed, the funding signals early investor confidence in the brand’s growth potential.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Dec 2025